Evidence map›Paper›PMID 33313679›Full record

ArticleEndocrinology2021

The PDZ Domain Protein SYNJ2BP Regulates GRK-Dependent Sst2A Phosphorylation and Downstream MAPK Signaling.

Heather S Carr, Jeffrey T Chang, Jeffrey A Frost

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. LowerCancer genomics & proteomics
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Heather S CarrDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Jeffrey T ChangDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Jeffrey A FrostDepartment of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, Houston, Texas, USA.
The University of Texas Health Science Center at Houston · US

Funding

Regulation of somatostatin receptor signaling by receptor interacting proteins.R01DK106357 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI FROST, JEFFREY A. · 2016 to 2019
$1.5M
ERK/MAP KINASE SIGNALLING PATHWAYSF32GM016926 · NIGMS · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI FROST, JEFFREY A · 1994 to 1996
–
NIDDK NIH HHS R01 DK106357NIGMS NIH HHS F32 GM016926
6 · The paper itself

Abstract

The somatostatin receptor 2A (SST2) is a G-protein-coupled receptor (GPCR) that is expressed in neuroendocrine tissues within the gastrointestinal tract and brain, and is commonly overexpressed in many neuroendocrine tumors. Moreover, SST2 agonists are used clinically as the primary pharmacological treatment to suppress excess hormone secretion in a variety of neuroendocrine tumors. Despite its wide clinical use, mechanisms controlling the trafficking and signaling of SST2 are not fully understood. SST2 contains a C-terminal post-synaptic density 95, Drosophila discs large, zona-occludens 1 (PDZ) domain-binding motif that has been shown to interact with 3 different PDZ domain-containing proteins. However, the consequences of these interactions are not well understood, nor is it known whether additional PDZ domain proteins interact with SST2. Through unbiased screening we have identified 10 additional PDZ domain proteins that interact with SST2. We chose one of these, SYNJ2BP, for further study. We observed that SYNJ2BP interacted with SST2 in an agonist-dependent manner, and that this required the PDZ binding site of SST2. Importantly, overexpression of SYNJ2BP enhanced ligand-stimulated receptor internalization. Mechanistically, SYNJ2BP interacted with G-protein-coupled receptor kinase 2 (GRK2) and promoted GRK-dependent phosphorylation of the receptor after somatostatin stimulation. Interaction with GRK2 required the C-terminus of SYNJ2BP. Binding to SYNJ2BP did not affect the ability of SST2 to suppress 3',5'-cyclic adenosine 5'-monophosphate production, but was required for optimal agonist-stimulated extracellularly regulated kinase 1/2 activation. These data indicated that SYNJ2BP is an SST2-interacting protein that modulates agonist-stimulated receptor regulation and downstream signaling.

Indexed as

MAP Kinase Signaling SystemPDZ DomainsExtracellular Signal-Regulated MAP KinasesG-Protein-Coupled Receptor Kinase 2HEK293 CellsHumansMembrane ProteinsPhosphorylationReceptors, SomatostatinExtracellular Signal-Regulated MAP KinasesG-Protein-Coupled Receptor Kinase 2GRK2 protein, humanMembrane ProteinsReceptors, Somatostatinsomatostatin receptor sst2ASYNJ2BP protein, humanGRK2MAPKPDZ domainsomatostatin receptor 2SYNJ2BP

Identifiers

PMID33313679
PMCPMC7799432
OpenAlexW3114521926

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.